CDER risk assessment exercise to evaluate potential risks from the use of nanomaterials in drug products.
Cruz CN, Tyner KM, Velazquez L, Hyams KC, Jacobs A, Shaw AB, Jiang W, Lionberger R, Hinderling P, Kong Y, Brown PC, Ghosh T, Strasinger C, Suarez-Sharp S, Henry D, Van Uitert M, Sadrieh N, Morefield E.
Cruz CN, et al. Among authors: van uitert m.
AAPS J. 2013 Jul;15(3):623-8. doi: 10.1208/s12248-013-9466-6. Epub 2013 Mar 20.
AAPS J. 2013.
PMID: 23512727
Free PMC article.